Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

NIOX Group PLC

Healthcare GB NIOX

61.0GBX
0.00(0%)

Last update at 2026-06-04T09:24:00Z

Day Range

59.4063.00
LowHigh

52 Week Range

53.8477.60
LowHigh

Fundamentals

  • Previous Close 61.00
  • Market Cap235.79M
  • Volume30786
  • P/E Ratio28.20
  • Dividend Yield2.83%
  • EBITDA14.30M
  • Revenue TTM48.70M
  • Revenue Per Share TTM0.12
  • Gross Profit TTM 33.70M
  • Diluted EPS TTM0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Income before tax 11.20M 7.80M 4.10M 4.10M 10.50M
Minority interest - - - - -
Net income 7.00M 3.70M 10.70M 10.70M 16.10M
Selling general administrative 20.40M 8.80M 8.40M 8.40M 7.50M
Selling and marketing expenses - 11.20M 11.20M 11.20M 9.70M
Gross profit 29.60M 30.20M 26.50M 26.50M 22.20M
Reconciled depreciation 4.10M 4.20M 4.40M - 4.60M
Ebit - 8.00M 4.20M 4.20M 10.60M
Ebitda 10.70M 12.20M 8.60M 8.60M 15.20M
Depreciation and amortization - 4.20M 4.40M 4.40M 4.60M
Non operating income net other - - - - -
Operating income 10.70M 7.70M 4.60M 4.60M 1.80M
Other operating expenses 38.00M 34.10M 32.20M 32.20M 29.50M
Interest expense 0.20M 0.20M 0.20M 0.20M 0.10M
Tax provision 4.20M 4.30M -5.40000M - -3.60000M
Interest income 0.40M 0.90M 0.80M - 0.30M
Net interest income 0.20M 0.70M 0.60M - 0.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 4.20M 4.40M -5.40000M -5.40000M -3.60000M
Total revenue 48.70M 41.80M 36.80M 36.80M 31.30M
Total operating expenses 18.90M 22.50M 21.90M 21.90M 20.40M
Cost of revenue 19.10M 11.60M 10.30M 10.30M 9.10M
Total other income expense net 0.50M 0.10M -0.50000M -0.50000M 8.70M
Discontinued operations - - - - -
Net income from continuing ops 7.00M 3.40M 9.50M - 14.10M
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Total assets 76.20M 68.40M 91.50M 91.50M 98.50M
Intangible assets 23.80M 23.50M 28.20M 28.20M 32.40M
Earning assets - - - - -
Other current assets - 6.20M - 4.70M -
Total liab 8.60M 8.90M 7.70M 7.70M 16.60M
Total stockholder equity 73.70M 59.50M 83.80M 83.80M 81.90M
Deferred long term liab - - - - -
Other current liab - 4.20M 4.10M 4.10M 6.70M
Common stock 0.30M 0.30M 0.30M 0.30M 0.30M
Capital stock 0.30M 0.30M 0.30M - 0.30M
Retained earnings 45.40M 43.40M 65.20M 65.20M -574.40000M
Other liab - - - - -
Good will 4.80M 4.30M 4.60M 4.60M 4.70M
Other assets - - - - -
Cash 19.90M 10.90M 19.90M 19.90M 19.40M
Cash and equivalents - - - - -
Total current liabilities 8.10M 8.10M 7.20M 7.20M 9.20M
Current deferred revenue - - - -0.60000M -
Net debt -18.90000M -9.40000M -18.80000M -18.80000M -18.40000M
Short term debt 0.50M 1.40M 1.20M 1.20M 1.20M
Short long term debt - - - - -
Short long term debt total 1.00M 1.50M 1.10M 1.10M 1.00M
Other stockholder equity 0.30M 0.20M 0.10M 0.10M 639.40M
Property plant equipment - - - - -
Total current assets 30.90M 21.10M 33.50M 33.50M 31.40M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 6.00M 6.20M 8.80M 8.80M 7.90M
Long term debt - - - - -
Inventory 5.00M 4.00M 4.80M 4.80M 4.10M
Accounts payable 7.60M 1.60M 1.10M 1.10M 0.50M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 27.70M 15.60M 18.20M 18.20M 16.60M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 23.80M -
Deferred long term asset charges - - - - -
Non current assets total 45.30M 47.30M 58.00M 58.00M 67.10M
Capital lease obligations 1.00M 1.50M 1.10M - 1.00M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Investments - -1.00000M -0.30000M - -0.10000M
Change to liabilities - - - - -
Total cashflows from investing activities -1.20000M -1.00000M -0.30000M -0.30000M -0.10000M
Net borrowings - - - - -
Total cash from financing activities -5.50000M -25.10000M -10.50000M -10.50000M -0.50000M
Change to operating activities - - - - -
Net income 7.00M 8.10M 5.30M 5.30M 12.50M
Change in cash 9.00M -9.00000M 0.50M 0.50M 6.80M
Begin period cash flow 10.90M 19.90M 19.40M 19.40M 12.60M
End period cash flow 19.90M 10.90M 19.90M 19.90M 19.40M
Total cash from operating activities 15.80M 17.20M 11.60M 11.60M 6.70M
Issuance of capital stock 0.10M 0.10M 0.10M - 0.00000M
Depreciation 4.10M 4.20M 4.40M 4.40M 4.60M
Other cashflows from investing activities 0.30M - -0.20000M -0.20000M -
Dividends paid 5.00M 4.20M 10.50M 10.50M -
Change to inventory -0.70000M 0.50M -0.80000M -0.80000M -1.40000M
Change to account receivables 0.50M 2.80M 2.70M 2.70M -6.70000M
Sale purchase of stock 0.00000M -21.30000M 0.00000M - -
Other cashflows from financing activities -0.60000M 0.80M 0.60M 0.60M 0.10M
Change to netincome - - - - -
Capital expenditures 0.20M 1.00M 0.30M 0.30M 0.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.40000M 3.20M -0.60000M -0.60000M -10.70000M
Stock based compensation 1.10M 1.90M 2.40M 2.40M 0.90M
Other non cash items 9.20M -0.20000M 0.10M 0.10M -0.60000M
Free cash flow 15.60M 16.20M 11.30M 11.30M 6.60M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NIOX
NIOX Group PLC		 - -% 61.00 28.20 18.73 4.84 3.41 4.35 13.85
SN
Smith & Nephew PLC		 8.50 0.77% 1117.00 23.24 12.47 1.70 2.59 2.67 10.76
EKF
EKF Diagnostics Holdings Plc		 0.10 0.38% 26.50 - 34.97 2.02 1.46 1.72 7.01
CREO
Creo Medical Group PLC		 0.25 1.82% 14.00 - - 199.36 0.74 6.21 8.16
AOTI
AOTI Inc		 -3.0 5.08% 56.00 18.25 8.10 0.64 2.76 0.94 8.31

Reports Covered

Stock Research & News

View All

Profile

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

NIOX Group PLC

Magdalen Centre, Oxford, United Kingdom, OX4 4GA

Key Executives

Name Title Year Born
Mr. Ian Roy Johnson Exec. Chairman 1954
Mr. Michael Roy David Roller A.C.A., ACA, BA (Hons) CFO & Director 1965
Mr. Jonathan Emms COO & Exec. Director NA
Ms. Nina Kataria Sr. VP Global HR NA
Mr. Tom Scaccia Sr. VP of Americas & Research Bus. NA
Ms. Sarah Duncan Company Sec. NA
Mr. Jonathan Charles Emms CEO & Executive Director 1963
Ms. Sarah Elizabeth Duncan CFO & Company Secretary NA
Mr. Tom Scaccia Senior Vice President of Americas & Research Business NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.